📰 Klinge Pharma News
Klinge Pharma News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Klinge Pharma. Real-time updates on events, politics, business and more.
August 2, 2023
02.08.2023 - – Net revenue rose 81% from prior quarter to $58.7 million –– CIMERLI net sales quadrupled to $26.7 million compared to prior quarter –– UDENYCA autoinjector launched in late May, and YUSIMRY launched in July –– Planned merger with Surface Oncology ...
June 16, 2023
Coherus to Acquire Surface Oncology - Surface acquisition and potential toripalimab approval will transform Coherus into an I-O company with multiple... | June 16, 2023
June 16, 2023
– Surface acquisition and potential toripalimab approval will transform Coherus into an I-O company with multiple next-generation immunotherapies in clinical development funded by growing... | June 16, 2023
June 16, 2023
–Surface acquisition and potential toripalimab approval will transform Coherus into an I-O company with multiplenext-generationimmunotherapies in clinical development funded bygrowing revenues –
May 8, 2023
– UDENYCA® autoinjector approved and ready for May 2023 launch –– CIMERLI® product-specific Q-code now facilitating electronic reimbursement following April 1 activation... | May 8, 2023